WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
Candice Swanepoel stuns in a form
Madrid Open: Rublev overcomes illness to win title
'China is behind this': MPs lash out at Beijing over cyber
Dortmund's Reus hopes to sign off in style
Ben Whishaw lights up the Croisette as he joins his co
Reigning champions Liaoning on verge of playoff exit
Reigning champions Liaoning on verge of playoff exit
Disney's streaming business turns a profit in first financial report since challenge to Iger
Candice Swanepoel stuns in a form
Leverkusen unbeaten run up to 48 after Frankfurt win
Hall of Fame outfielder Ken Griffey Jr. to lead Indianapolis 500 field in Corvette pace car
Indiana professors sue after GOP lawmakers pass law regulating faculty tenure